Cargando…
Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
Apixaban is frequently used off‐label in transplant recipients. However, a potential drug interaction exists with the calcineurin inhibitors. We conducted an open‐label drug–drug interaction study to determine the pharmacokinetics of apixaban in lung and kidney transplant recipients who were taking...
Autores principales: | Mansell, Holly, Shoker, Ahmed, Alcorn, Jane, Fenton, Mark E., Tam, Julian S., Semchuk, William, Bashir, Babar, Kraft, Walter K., Yao, Shenzhen, Douketis, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283751/ https://www.ncbi.nlm.nih.gov/pubmed/35439353 http://dx.doi.org/10.1111/cts.13284 |
Ejemplares similares
-
Drug‐Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
por: Bashir, Babar, et al.
Publicado: (2018) -
Validity of Cardiovascular Risk Prediction Models in Kidney Transplant Recipients
por: Mansell, Holly, et al.
Publicado: (2014) -
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014) -
Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events
por: Mansell, Holly, et al.
Publicado: (2015) -
Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C(0) and AUC
por: Radzevičienė, Aurelija, et al.
Publicado: (2020)